HOT: HIPEC in Ovarian Cancer as Initial Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Epistemonikos ID: ea58f1fe06387cf5211147c963f8cab305cbe0e2
First added on: May 11, 2024